# TESTOSTERONE
> **ANDA209533** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2018-01-29
## Drug
- **FDA Application Number:** ANDA209533
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TESTOSTERONE
- **Generic name:** TESTOSTERONE
- **Active ingredients:** TESTOSTERONE
- **Dosage form:** SOLUTION, METERED
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **Manufacturer:** Cipla USA Inc.
- **First approval:** 2018-01-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209533)
---
*AI Analytics · CC0 1.0*